semaglutide: findings from clinical trials Clinical trials have shown that in just over a year, semaglutide led to an average loss of 14.9% of overall body weight, while liraglutide led to an average loss of 8%
When your study spans a year, you can't afford to have your foundational tool be a variable
liraglutide: Head-to-head study reveals a diabetes risk difference Popular diabetes drugs do not alter the risk of developing a blinding eye condition Other side effects include hypoglycemia, especially when combined with other diabetes medications, fatigue, headache, and dizziness
It is not appropriate for everyone, which is why conditions such as liver, kidney, or cardiac disease and pregnancy are screened first
Patients and plaintiffs lawyers argue that Novo Nordisk failed to warn prescribing physicians and patients about the risks of delayed gastric emptying and other serious side effects
Whilst IBD is not caused by Ozempic, patients with undiagnosed IBD may coincidentally be prescribed the medication